@article{9e25153a3f88402a8dde87b72a344e25,
title = "The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors",
abstract = "Immunoreceptor tyrosine-based activation motifs (ITAMs) are crucial in antigen receptor signaling in acquired immunity. Although receptors associated with the ITAM-bearing adaptors FcRγ and DAP12 on myeloid cells have been suggested to activate innate immune responses, the mechanism coupling those receptors to 'downstream' signaling events is unclear. The CARMA1-Bcl-10-MALT1 complex is critical for the activation of transcription factor NF-κB in lymphocytes but has an unclear function in myeloid cells. Here we report that deletion of the gene encoding the Bcl-10 adaptor-binding partner CARD9 resulted in impaired myeloid cell activation of NF-κB signaling by several ITAM-associated receptors. Moreover, CARD9 was required for Toll-like receptor-induced activation of dendritic cells through the activation of mitogen-activated protein kinases. Although Bcl10-/- and Card9-/- mice had similar signaling impairment in myeloid cells, Card11-/- (CARMA1-deficient) myeloid cell responses were normal, and although Card11-/- lymphocytes were defective in antigen receptor-mediated activation, Card9-/- lymphocytes were not. Thus, the activation of lymphoid and myeloid cells through ITAM-associated receptors or Toll-like receptors is regulated by CARMA1-Bcl-10 and CARD9-Bcl-10, respectively.",
author = "Hiromitsu Hara and Chitose Ishihara and Arata Takeuchi and Takayuki Imanishi and Liquan Xue and Morris, {Stephan W.} and Masanori Inui and Toshiyuki Takai and Akira Shibuya and Shinobu Saijo and Yoichiro Iwakura and Naohito Ohno and Haruhiko Koseki and Hiroki Yoshida and Penninger, {Josef M.} and Takashi Saito",
note = "Funding Information: We thank N. Suzuki, S. Yamasaki, and T. Yokosuka for discussions; H. Arase (Osaka University) and N. Kanazawa (Wakayama Medical University) for reagents; S. Akira (Osaka University) for Myd88–/– mice and Tlr2–/–; X. Lin (University of Texas M.D. Anderson Cancer Center) for reagents, discussions and sharing unpublished data; and H. Yamaguchi and M. Ikari for secretarial assistance. Expression plasmids pCMVSPORT-IRAK1, pcDNA3-RIP2–myc and pRK6–myc-Bcl-10 were provided by T.W. Mak (Campbell Family Institute for Breast Cancer Research and Ontario Cancer Institue), N. Inohara (The University of Michigan Medical School) and X. Lin (University of Texas M.D. Anderson Cancer Center), respectively. Supported by a Grant-in-Aid for Priority Area Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the National Cancer Institute (R01 CA87064 to S.W.M.), Cancer Center (CORE grant CA21765), the Council of Scientific and Industrial Research (Government of India; S.K.P.), the Department of Biotechnology (Government of India) and the American Lebanese Syrian Associated Charities of St. Jude Children{\textquoteright}s Research Hospital.",
year = "2007",
month = jun,
doi = "10.1038/ni1466",
language = "English",
volume = "8",
pages = "619--629",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "6",
}